Recro Pharma CEO Discusses Strong Results In Non-Opioid Pain Treatment Study
December 01, 2016 at 10:49 AM EST
Recro Pharma Inc (NASDAQ: REPH) is a micro-cap specialty pharmaceutical company focused on the development of non-opioid products for ...